SA cancer research company entering Dallas market as it eyes more U.S., European expansion


A cancer research company based in San Antonio is entering the Dallas market as it eyes more U.S. and European expansion

Previous Here's how much Fiserv CEO Bisignano earned in 2022
Next UPMC Enterprises' long-term portfolio company Prodigo Solutions takes next step